Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type |
A1 | 1 | 42 | F | Nose | Squamous cell carcinoma | 1 | T1N0M0 | I | Malignant |
A2 | 2 | 38 | F | Breast | Medullary carcinoma | * | T2N0M0 | IIA | Malignant |
A3 | 3 | 73 | M | Lymph node | B-cell lymphoma | * | * | * | Malignant |
A4 | 4 | 42 | F | Uterine cervix | Squamous cell carcinoma (fibrous tissue and blood vessel) | * | T2N0M1 | IV | Malignant |
A5 | 5 | 82 | M | Prostate | Adenocarcinoma (Gleason grade:3 Gleason score:3+3) | 2 | T2N0M0 | II | Malignant |
A6 | 6 | 74 | M | Pancreas | Duct adenocarcinoma | 1 | T3N0M0 | II | Malignant |
A7 | 7 | 45 | F | Ovary | Serous adenocarcinoma | 1 | T1N0M0 | I | Malignant |
A8 | 8 | 83 | M | Bladder | Transitional cell carcinoma | 1 | T2aN0M0 | IIA | Malignant |
A9 | 9 | 60 | F | Kidney | Clear cell carcinoma | 1 | T2N0M0 | II | Malignant |
B1 | 10 | 74 | M | Nose | Squamous cell carcinoma | 2 | T2N0M0 | II | Malignant |
B2 | 11 | 60 | F | Breast | Invasive ductal carcinoma | 2 | T4N0M0 | IIIB | Malignant |
B3 | 12 | 6 | F | Lymph node | Diffuse T-cell lymphoma of left neck | * | * | * | Malignant |
B4 | 13 | 57 | F | Uterine cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant |
B5 | 14 | 69 | M | Prostate | Adenocarcinoma (Gleason grade:2 Gleason score:2+1) | 1 | T2N0M0 | II | Malignant |
B6 | 15 | 62 | M | Pancreas | Duct adenocarcinoma | 2 | T3N1M0 | IIB | Malignant |
B7 | 16 | 45 | F | Ovary | Serous adenocarcinoma | 2 | T3bN0M0 | IIIB | Malignant |
B8 | 17 | 70 | M | Bladder | Transitional cell carcinoma | 1 | T2N0M0 | II | Malignant |
B9 | 18 | 77 | M | Kidney | Clear cell carcinoma | 2 | T2N0M0 | II | Malignant |
C1 | 19 | 43 | M | Nose | Squamous cell carcinoma (sparse) | 3 | T3N0M0 | III | Malignant |
C2 | 20 | 59 | F | Breast | Invasive ductal carcinoma | 3 | T2N0M0 | IIA | Malignant |
C3 | 21 | 40 | M | Lymph node | T-cell lymphoma | * | * | * | Malignant |
C4 | 22 | 46 | F | Uterine cervix | Squamous cell carcinoma | 2 | T2N0M1 | IV | Malignant |
C5 | 23 | 70 | M | Prostate | Adenocarcinoma (Gleason grade:4 Gleason score:4+5) | 3 | T3N1M0 | IV | Malignant |
C6 | 24 | 65 | M | Pancreas | Duct adenocarcinoma | 2 | T3N1M0 | IIB | Malignant |
C7 | 25 | 40 | F | Ovary | Adenocarcinoma | 3 | T1N0M0 | I | Malignant |
C8 | 26 | 54 | M | Bladder | Mucinous adenocarcinoma | 2 | T3aN0M0 | III | Malignant |
C9 | 27 | 52 | F | Kidney | Clear cell carcinoma | 1 | T2N0M0 | II | Malignant |
D1 | 28 | 40 | M | Nose | Adjacent normal cryptae of mucous membrane | * | * | * | NAT |
D2 | 29 | 56 | F | Breast | Adjacent normal breast tissue | * | * | * | NAT |
D3 | 30 | 40 | M | Lymph node | Lymph node tissue | * | * | * | Normal |
D4 | 31 | 72 | F | Uterine cervix | Adjacent normal cervix tissue | * | * | * | NAT |
D5 | 32 | 36 | M | Prostate | Prostate tissue | * | * | * | Normal |
D6 | 33 | 50 | M | Pancreas | Pancreas tissue | * | * | * | Normal |
D7 | 34 | 35 | F | Ovary | Adjacent normal ovary tissue | * | * | * | NAT |
D8 | 35 | 38 | M | Bladder | Bladder tissue | * | * | * | Normal |
D9 | 36 | 48 | M | Kidney | Adjacent normal kidney tissue | * | * | * | NAT |
E1 | 37 | 34 | M | Skin | Squamous cell carcinoma | 1 | T1N0M0 | I | Malignant |
E2 | 38 | 50 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
E3 | 39 | 63 | F | Colon | Adenocarcinoma (fibrous tissue and blood vessel) | * | T3N0M0 | IIA | Malignant |
E4 | 40 | 35 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
E5 | 41 | 50 | M | Cerebrum | Malignant meningioma | * | * | * | Malignant |
E6 | 42 | 54 | M | Rectum | Adenocarcinoma | 1 | T3N0M0 | IIA | Malignant |
E7 | 43 | 39 | M | Esophagus | Squamous cell carcinoma | 2 | T2N1M0 | IIB | Malignant |
E8 | 44 | 43 | M | Stomach | Adenocarcinoma | 1 | T2bN0M0 | IB | Malignant |
E9 | 45 | 52 | M | Lung | Bronchioloalveolar carcinoma | * | T2N0M0 | IB | Malignant |
F1 | 46 | 57 | M | Skin | Squamous cell carcinoma | 2 | T2N0M0 | II | Malignant |
F2 | 47 | 55 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant |
F3 | 48 | 49 | M | Colon | Adenocarcinoma | 1 | T4N0M0 | IIB | Malignant |
F4 | 49 | 61 | F | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
F5 | 50 | 53 | M | Cerebrum | Malignant meningioma | * | * | * | Malignant |
F6 | 51 | 51 | F | Rectum | Adenocarcinoma | 2 | T3N1M0 | IIIB | Malignant |
F7 | 52 | 75 | F | Esophagus | Squamous cell carcinoma | 1 | T3N1M0 | III | Malignant |
F8 | 53 | 70 | M | Stomach | Adenocarcinoma | * | T2bN0M0 | IB | Malignant |
F9 | 54 | 35 | F | Lung | Adenosquamous carcinoma | 3 | T2N0M0 | IB | Malignant |
G1 | 55 | 80 | F | Skin | Basal cell carcinoma of head | * | T1N0M0 | I | Malignant |
G2 | 56 | 52 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1cN0M0 | IC | Malignant |
G3 | 57 | 50 | F | Colon | Undifferentiated carcinoma | * | T3N0M0 | II | Malignant |
G4 | 58 | 51 | M | Liver | Compounded hepatocellular carcinoma | * | T2N0M0 | II | Malignant |
G5 | 59 | 41 | F | Cerebrum | Malignant meningioma | * | * | * | Malignant |
G6 | 60 | 35 | F | Rectum | Signet-ring cell carcinoma | * | T3N1M0 | IIIB | Malignant |
G7 | 61 | 60 | M | Esophagus | Squamous cell carcinoma | 2 | T3N0M0 | IIA | Malignant |
G8 | 62 | 69 | F | Stomach | Adenocarcinoma | 3 | T2bN0M0 | IB | Malignant |
G9 | 63 | 46 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
H1 | 64 | 48 | F | Skin | Adjacent normal skin tissue | * | * | * | NAT |
H2 | 65 | 41 | F | Uterus | Endometrium tissue (sparse) | * | * | * | Normal |
H3 | 66 | 30 | M | Colon | Colon tissue (smooth muscle) | * | * | * | Normal |
H4 | 67 | 32 | M | Liver | Adjacent normal liver tissue | * | * | * | NAT |
H5 | 68 | 47 | M | Cerebrum | Brain tissue | * | * | * | Normal |
H6 | 69 | 35 | M | Rectum | Rectum tissue | * | * | * | Normal |
H7 | 70 | 51 | F | Esophagus | Adjacent normal esophagus tissue (smooth muscle) | * | * | * | NAT |
H8 | 71 | 48 | M | Stomach | Stomach tissue | * | * | * | Normal |
H9 | 72 | 15 | F | Lung | Lung tissue | * | * | * | Normal |
Tissue Marker |